| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
28,585
|
31,819
|
26,344
|
24,554
| | Cost of Revenue | 6,291 | 6,374 | 5,530 | 5,413 | | |
Gross Profit
|
22,294
|
25,445
|
20,814
|
19,141
| |
|
Operating Expenses |
|
Research Development | 6,358 | 5,483 | 5,154 | 4,925 |
|
Selling General and Administrative | 21,930 | 20,804 | 17,322 | 15,665 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(5,994)
|
(842)
|
(1,662)
|
(1,449)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (47) |
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | (6,041) | (959) | (1,729) | (1,438) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (6,041) | (959) | (1,729) | (1,438) |
|
Income Tax Expense | 154 | (97) | 262 | 227 |
|
Minority Interest | 136 | 138 | 132 | 132 |
|
|
|
Net Income From Continuing Ops | (6,059) | (724) | (1,859) | (1,533) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(6,059)
|
(724)
|
(1,859)
|
(1,533)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(6,059)
|
(724)
|
(1,859)
|
(1,533)
|
|